[ad_1]
Authorities in the Vorpommern-Rügen district in the northern German city of Stralsund announced that employees received five times the recommended dose of Pfizer-Biontech vaccine on Sunday.
Four of the eight developed flu-like symptoms and were hospitalized for observation.
“I deeply regret this incident. It is an individual case linked to an individual error. I hope that those affected do not have serious side effects,” District Chief Stefan Kerth said in a statement.
Representatives for Vorpommern-Rügen note at the same time that Biontech in previous statements said that larger doses were tested during the trial period without this having serious consequences.
It emerged on Sunday that the German vaccination program had been delayed in several cities due to alleged problems in the cold chain.
The vaccine developed by Pfizer-Biontech is a so-called mRNA vaccine, which requires storage and storage at minus 70 degrees.
.
[ad_2]
